首页> 外文期刊>Applied Microbiology >Interaction of Lactobacillus fermentum BGHI14 with Rat Colonic Mucosa: Implications for Colitis Induction
【24h】

Interaction of Lactobacillus fermentum BGHI14 with Rat Colonic Mucosa: Implications for Colitis Induction

机译:发酵乳杆菌BGHI14与大鼠结肠粘膜的相互作用:对结肠炎诱导的影响。

获取原文
       

摘要

The present study was carried out to test the colonic mucosal response of rats to oral supplementation with Lactobacillus fermentum BGHI14 and to correlate the tissue reaction to trinitrobenzenesulfonate (TNBS)-induced colitis with mucosal barrier alterations caused by bacterial ingestion. An immune cell-mediated reaction of healthy colonic tissue was noticed after bacterial feeding. After prolonged bacterial treatment, the observed reaction had retreated to normality, but the mRNA levels of proinflammatory cytokines interleukin-1β (IL-1β) and tumor necrosis factor alpha (TNF-α) remained elevated. These data point to the chronic low-grade inflammation that could be caused by long-term probiotic consumption. Although no detrimental effects of bacterial pretreatment were noticed in colitic rats, at least in the acute state of disease, the results obtained in our study point to the necessity of reassessment of existing data on the safety of probiotic preparations. Additionally, probiotic effects in experimental colitis models might depend on time coordination of disease induction with treatment duration.
机译:本研究旨在测试大鼠口服发酵乳杆菌BGHI14后的结肠粘膜反应,并将组织对三硝基苯磺酸盐(TNBS)诱发的结肠炎的反应与细菌摄入引起的粘膜屏障改变相关联。细菌喂养后,发现了健康结肠组织的免疫细胞介导反应。长时间的细菌治疗后,观察到的反应已恢复正常,但促炎细胞因子白细胞介素-1β(IL-1β)和肿瘤坏死因子α(TNF-α)的mRNA水平仍然升高。这些数据表明,长期食用益生菌可能导致慢性低度炎症。尽管在结肠炎大鼠中没有注意到细菌预处理的有害影响,至少在疾病的急性状态下,但我们的研究结果表明有必要重新评估益生菌制剂安全性的现有数据。另外,实验性结肠炎模型中的益生菌作用可能取决于疾病诱导时间与治疗持续时间的协调。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号